Concordia Healthcare acquires legacy pharmaceutical products and acquires and develops orphan drugs.
Concordia is focused on acquiring Specialty Healthcare and Pharmaceutical Distribution companies.
Concordia Healthcare is listed on the TSX Exchange under (TSX:CXR).
February 19, 2014
CONCORDIA HEALTHCARE CORP. ANNOUNCES INCREASE OF PREVIOUSLY ANNOUNCED EQUITY FINANCING TO $58.75 MILLION ...
February 18, 2014
CONCORDIA HEALTHCARE CORP. ANNOUNCES $35.0 MILLION BOUGHT DEAL FINANCING THIS NEWS RELEASE IS INTENDED ...